Document Detail


Preparation, Characterization and In Vivo Evaluation of pH-sensitive Oral Insulin-Loaded PLGA Nanoparticles.
MedLine Citation:
PMID:  22151795     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aims: Oral administration of insulin is a promising drug delivery system for diabetic patients as it is convenient and reduces pain, two of the major contributors to non-compliance. Materials and methods: In the present study, insulin was encapsulated in poly (lactic-co-glycolicacid) (PLGA) nanoparticles (NPs) by using double-emulsion/solvent evaporation technique and studies on its release kinetics were carried out using both in vitro and in vivo methods. Results: First only by this simple methods, release speed of insulin from NPs can be controlled in different PH solution. The rate of release of insulin was found to be slower in acidic pH; about 90% of insulin was released in 11 days at pH 1.0. In alkaline conditions, the release was faster; about 90% release was observed to occur within 3 days at pH 7.8. The insulin loaded PLGA NPs (PINPs) were administered orally to diabetes mellitus-induced rats and the response of blood glucose and insulin levels was estimated. Blood glucose decreased and the concentration of insulin in animal blood increased. In diabetic animals which were administered intermittent insulin, every eight hours, blood glucose levels were maintained equivalently with those of healthy rats. Conclusion: These experimental results indicated that oral PINPs are able to deliver insulin effectively and decrease animal blood sugar; in conclusion, this may be a promising delivery system for the treatment of diabetes.
Authors:
Jing Yang; Hongfan Sun; Cunxian Song
Related Documents :
22198815 - Oral salmon calcitonin improves fasting and postprandial glycemic control in lean healt...
8083355 - Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
16732015 - The 11482g >a polymorphism in the perilipin gene is associated with weight gain with ro...
19598005 - Methyltetrahydrofolate reductase c677t gene mutation and hyperhomocysteinemia as a nove...
7646105 - Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
6379315 - Development of remotely controlled implantable devices for programmed insulin infusion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-8
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  -     ISSN:  1463-1326     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Blackwell Publishing Ltd.
Affiliation:
The Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Biomaterial Research, Tianjin 300192, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatit...
Next Document:  Early and late calcium waves during wound healing in corneal endothelial cells.